Harnessing Mesenchymal Stem Cell‐Derived EVs‐Loaded Hydrogels: Therapeutic Mechanisms and Applications in Retinal Injury Repair (Adv. Healthcare Mater. 17/2026)
Source abstract
Abstract
Retinal Repair Retinal damage is a leading cause of irreversible vision loss, and conventional treatments have limited efficacy. Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) show promise for retinal repair because of their low immunogenicity and anti-inflammatory, antioxidant, and neuroprotective properties. However, rapid clearance and frequent dosing limit clinical use. Hydrogel delivery systems improve intraocular retention and bioavailability, thereby enhancing therapeutic outcomes. More details can be found in the Review Article by Huanan Wang, Lijun Zhang, Chuanfeng An, and co-workers (DOI: 10.1002/adhm.202502691).
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Corneal Surgery and Treatments · Neuroscience and Neural Engineering · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.